BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

20/20GENE SYSTEMS — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

20/20GENE SYSTEMS

via JD LISS ASSOCIATES FORMERLY KNOWN AS JONATHAN DAVID LISS

2nd Quarter (Apr 1 - June 30) · 2023Posted Aug 4, 2023Filing document ↗LDA record ↗

Income$26Kfee reported

Client

Name: 20/20GENE SYSTEMS
Description: Development of innovative laboratory tests
Location: Maryland · United States of America

Registrant

Firm: JD LISS ASSOCIATES FORMERLY KNOWN AS JONATHAN DAVID LISS
Description: Consulting and lobbying
Location: METUCHEN, New Jersey, United States of America

Lobbying activities

1 issue

Health Issues
Multi Cancer Early Detection Legislation seeking Medicare reimbursement for tests that detect multiple cancers early
LobbyistsJONATHAN DAVID LISS
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.